Jonathan Freve - Net Worth and Insider Trading
Jonathan Freve Net Worth
The estimated net worth of Jonathan Freve is at least $28,412 dollars as of 2024-06-01. Jonathan Freve is the CFO & Treasurer of Spring Bank Pharmaceuticals Inc and owns about 4,370 shares of Spring Bank Pharmaceuticals Inc (SBPH) stock worth over $21,151. Jonathan Freve is also the CFO of Galecto Inc and owns about 12,000 shares of Galecto Inc (GLTO) stock worth over $7,261. Details can be seen in Jonathan Freve's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan Freve has not made any transactions after 2021-12-03 and currently still holds the listed stock(s).
Transaction Summary of Jonathan Freve
Jonathan Freve Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan Freve owns 3 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , F-star Therapeutics Inc (FSTX) , and Galecto Inc (GLTO) .
Click here to see the complete history of Jonathan Freve’s form 4 insider trades.
Insider Ownership Summary of Jonathan Freve
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-03-05 | CFO & Treasurer |
| FSTX | F-star Therapeutics Inc | 2016-05-05 | CFO & Treasurer & Secretary |
| GLTO | Galecto Inc | 2021-12-03 | Chief Financial Officer |
Jonathan Freve Latest Holdings Summary
Jonathan Freve currently owns a total of 2 stocks. Among these stocks, Jonathan Freve owns 4,370 shares of Spring Bank Pharmaceuticals Inc (SBPH) as of November 14, 2019, with a value of $21,151 and a weighting of 74.44%. Jonathan Freve also owns 12,000 shares of Galecto Inc (GLTO) as of December 3, 2021, with a value of $7,261 and a weighting of 25.56%.
Latest Holdings of Jonathan Freve
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2019-11-14 | 4,370 | 4.84 | 21,151 |
| GLTO | Galecto Inc | 2021-12-03 | 12,000 | 0.61 | 7,261 |
Holding Weightings of Jonathan Freve
Jonathan Freve Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan Freve has made a total of 1 transactions in Spring Bank Pharmaceuticals Inc (SBPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Spring Bank Pharmaceuticals Inc is the acquisition of 1,250 shares on November 14, 2019, which cost Jonathan Freve around $15,200.
According to the SEC Form 4 filings, Jonathan Freve has made a total of 3 transactions in Galecto Inc (GLTO) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Galecto Inc is the acquisition of 4,000 shares on December 3, 2021, which cost Jonathan Freve around $9,960.
Insider Trading History of Jonathan Freve
- 1
Jonathan Freve Trading Performance
GuruFocus tracks the stock performance after each of Jonathan Freve's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan Freve is -31.03%. GuruFocus also compares Jonathan Freve's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan Freve within 3 months outperforms 0 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan Freve's insider trading performs compared to the benchmark.
Performance of Jonathan Freve
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.44 | | | | | |
| Relative Return to S&P 500(%) | 2.41 | | | | | |
Jonathan Freve Ownership Network
Jonathan Freve Owned Company Details
What does Spring Bank Pharmaceuticals Inc do?
Who are the key executives at Spring Bank Pharmaceuticals Inc?
Jonathan Freve is the CFO & Treasurer of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , director & President and CEO Martin J Driscoll , and Chief Scientific Officer Radhakrishnan P. Iyer .
Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spring Bank Pharmaceuticals Inc Insider Transactions
Jonathan Freve Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan Freve. You might contact Jonathan Freve via mailing address: C/o Spring Bank Pharmaceuticals, Inc., 113 Cedar Street, Ste S-7, Milford Ma 01757.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
